
Tocilizumab cuts progression to ventilation or death in COVID-19
(HealthDay)—Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study published online Dec. 18 in the New England Journal of Medicine.
Dec 18, 2020
1
3